Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-6-7
pubmed:abstractText
This study was performed to determine the safety and efficacy of belotecan, a new camptothecin analogue and potent topoisomerase I inhibitor, with and without platinum in patients with recurrent ovarian cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1537-453X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
233-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19745693-Adult, pubmed-meshheading:19745693-Aged, pubmed-meshheading:19745693-Antineoplastic Agents, Phytogenic, pubmed-meshheading:19745693-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19745693-Camptothecin, pubmed-meshheading:19745693-Carcinoma, pubmed-meshheading:19745693-Cisplatin, pubmed-meshheading:19745693-Disease-Free Survival, pubmed-meshheading:19745693-Drug Resistance, Neoplasm, pubmed-meshheading:19745693-Female, pubmed-meshheading:19745693-Hematologic Diseases, pubmed-meshheading:19745693-Humans, pubmed-meshheading:19745693-Middle Aged, pubmed-meshheading:19745693-Neoplasm Recurrence, Local, pubmed-meshheading:19745693-Organoplatinum Compounds, pubmed-meshheading:19745693-Ovarian Neoplasms, pubmed-meshheading:19745693-Salvage Therapy, pubmed-meshheading:19745693-Survival Analysis, pubmed-meshheading:19745693-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Efficacy and toxicity of belotecan with and without cisplatin in patients with recurrent ovarian cancer.
pubmed:affiliation
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Women's Cancer Clinic, Yonsei University College of Medicine, Seongsan-no 250, Seodaemun-gu, Seoul, Korea.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't